Differentiation and Apoptosis in Human Immortalized Sebocytes

Increased cell volume, accumulation of lipid droplets in the cytoplasm, and nuclear degeneration are phenomena indicating terminal differentiation of human sebocytes followed by holocrine secretion and cell death. The molecular pathways of natural and induced sebocyte elimination are still unknown,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of investigative dermatology 2003-02, Vol.120 (2), p.175-181
Hauptverfasser: Wróbel, Anna, Seltmann, Holger, Fimmel, Sabine, Müller-Decker, Karin, Tsukada, Miki, Bogdanoff, Birgit, Mandt, Nathalie, Blume-Peytavi, Ulrike, Orfanos, Constantin E., Zouboulis, Christos C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 181
container_issue 2
container_start_page 175
container_title Journal of investigative dermatology
container_volume 120
creator Wróbel, Anna
Seltmann, Holger
Fimmel, Sabine
Müller-Decker, Karin
Tsukada, Miki
Bogdanoff, Birgit
Mandt, Nathalie
Blume-Peytavi, Ulrike
Orfanos, Constantin E.
Zouboulis, Christos C.
description Increased cell volume, accumulation of lipid droplets in the cytoplasm, and nuclear degeneration are phenomena indicating terminal differentiation of human sebocytes followed by holocrine secretion and cell death. The molecular pathways of natural and induced sebocyte elimination are still unknown, however. In this study, SZ95 sebocytes were found to exhibit DNA fragmentation after a 6 h culture followed by increased lactate dehydrogenase release after 24 h, indicating cell damage. With the help of morphologic studies and using Oil Red detection of cellular lipids, cell enlargement, accumulation of lipid droplets in the cytoplasm, and nuclear fragmentation could be observed under treatment with arachidonic acid. Staurosporine, a potent inhibitor of phospholipid Ca2+-dependent protein kinase, increased externalized phosphatidylserine levels on SZ95 sebocytes, detected by annexin V/propidium iodide flow cytometry, as early as after 1 h, whereas dose-dependent reduction of bcl-2 mRNA and protein expression, enhanced DNA fragmentation, and increased caspase 3 levels, detected by caspase 3 inhibitor/propidium iodide flow cytometry, were found after 6 h of treatment. SZ95 sebocyte death was detected as early as after 6 h of SZ95 sebocyte treatment with high staurosporine concentrations (10−6–10−5 M). 5α-Dihydrotestosterone (10−8–10−5 M) did not affect externalized phosphatidylserine levels and DNA fragmentation in SZ95 sebocytes but slightly decreased lactate dehydrogenase cell release. Neither acitretin nor 13-cis retinoic acid (10−8–10−5 M) affected externalized phosphatidylserine levels, DNA fragmentation, and lactate dehydrogenase cell release, despite the increased caspase 3 levels under treatment with 13-cis retinoic acid. The combined staurosporine and 13-cis retinoic acid treatment enhanced DNA fragmentation in SZ95 sebocytes to the same magnitude as in cells only treated with staurosporine. In conclusion, SZ95 sebocytes in vitro undergo apoptosis, which can be enhanced by the terminal differentiation inductor arachidonic acid or by staurosporine and leads to cell death. 5α-Dihydrotestosterone inhibits SZ95 sebocyte death without involving apoptotic pathways, and retinoids did not affect the programmed death of human sebocytes. The latter result fits well with the currently reported inability of normal skin cells to undergo apoptosis after treatment with retinoids, in contrast to their malignant counterparts.
doi_str_mv 10.1046/j.1523-1747.2003.12029.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72977976</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022202X15301688</els_id><sourcerecordid>1038893991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543t-c15439ac811329d951e554c036c31d58d47d6db4d74ff78ce36548b335a6a2d3</originalsourceid><addsrcrecordid>eNqFkEtP3DAUhS1EBVPKX0AREuyS-hnHCxY8WkBC6qIs2Fke-0byKLEHO0HAr6-nMyoSm67u4nzn6OpDqCK4IZi331cNEZTVRHLZUIxZQyimqnndQ4t_wT5aYExpXZKnQ_Q15xXGpOWiO0CHhApOBVELdHHj-x4ShMmbycdQmeCqy3VcTzH7XPlQ3c2jCdX9OMY0mcG_g6t-wzLatwnyN_SlN0OG4909Qo8_fzxe39UPv27vry8fais4m2pLylHGdoQwqpwSBITgFrPWMuJE57h0rVtyJ3nfy84CawXvlowJ0xrq2BE6386uU3yeIU969NnCMJgAcc5aUiWlkm0BTz-BqzinUF7TlGBWOKoK1G0hm2LOCXq9Tn406U0TrDd69UpvLOqNRb3Rq__q1a-lerLbn5cjuI_izmcBznaAydYMfTLB-vzBcUUFpl3hrrYcFGsvHpLO1kOw4HwCO2kX_f-_-QPAKJdQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210372929</pqid></control><display><type>article</type><title>Differentiation and Apoptosis in Human Immortalized Sebocytes</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Wróbel, Anna ; Seltmann, Holger ; Fimmel, Sabine ; Müller-Decker, Karin ; Tsukada, Miki ; Bogdanoff, Birgit ; Mandt, Nathalie ; Blume-Peytavi, Ulrike ; Orfanos, Constantin E. ; Zouboulis, Christos C.</creator><creatorcontrib>Wróbel, Anna ; Seltmann, Holger ; Fimmel, Sabine ; Müller-Decker, Karin ; Tsukada, Miki ; Bogdanoff, Birgit ; Mandt, Nathalie ; Blume-Peytavi, Ulrike ; Orfanos, Constantin E. ; Zouboulis, Christos C.</creatorcontrib><description>Increased cell volume, accumulation of lipid droplets in the cytoplasm, and nuclear degeneration are phenomena indicating terminal differentiation of human sebocytes followed by holocrine secretion and cell death. The molecular pathways of natural and induced sebocyte elimination are still unknown, however. In this study, SZ95 sebocytes were found to exhibit DNA fragmentation after a 6 h culture followed by increased lactate dehydrogenase release after 24 h, indicating cell damage. With the help of morphologic studies and using Oil Red detection of cellular lipids, cell enlargement, accumulation of lipid droplets in the cytoplasm, and nuclear fragmentation could be observed under treatment with arachidonic acid. Staurosporine, a potent inhibitor of phospholipid Ca2+-dependent protein kinase, increased externalized phosphatidylserine levels on SZ95 sebocytes, detected by annexin V/propidium iodide flow cytometry, as early as after 1 h, whereas dose-dependent reduction of bcl-2 mRNA and protein expression, enhanced DNA fragmentation, and increased caspase 3 levels, detected by caspase 3 inhibitor/propidium iodide flow cytometry, were found after 6 h of treatment. SZ95 sebocyte death was detected as early as after 6 h of SZ95 sebocyte treatment with high staurosporine concentrations (10−6–10−5 M). 5α-Dihydrotestosterone (10−8–10−5 M) did not affect externalized phosphatidylserine levels and DNA fragmentation in SZ95 sebocytes but slightly decreased lactate dehydrogenase cell release. Neither acitretin nor 13-cis retinoic acid (10−8–10−5 M) affected externalized phosphatidylserine levels, DNA fragmentation, and lactate dehydrogenase cell release, despite the increased caspase 3 levels under treatment with 13-cis retinoic acid. The combined staurosporine and 13-cis retinoic acid treatment enhanced DNA fragmentation in SZ95 sebocytes to the same magnitude as in cells only treated with staurosporine. In conclusion, SZ95 sebocytes in vitro undergo apoptosis, which can be enhanced by the terminal differentiation inductor arachidonic acid or by staurosporine and leads to cell death. 5α-Dihydrotestosterone inhibits SZ95 sebocyte death without involving apoptotic pathways, and retinoids did not affect the programmed death of human sebocytes. The latter result fits well with the currently reported inability of normal skin cells to undergo apoptosis after treatment with retinoids, in contrast to their malignant counterparts.</description><identifier>ISSN: 0022-202X</identifier><identifier>EISSN: 1523-1747</identifier><identifier>DOI: 10.1046/j.1523-1747.2003.12029.x</identifier><identifier>PMID: 12542519</identifier><identifier>CODEN: JIDEAE</identifier><language>eng</language><publisher>Danvers, MA: Elsevier Inc</publisher><subject>apoptosis ; Arachidonic Acid - pharmacology ; bcl-2-Associated X Protein ; Biological and medical sciences ; Caspase 3 ; Caspases - metabolism ; Cell Differentiation - drug effects ; Cell Differentiation - physiology ; cell line ; Cell Line, Transformed ; Dermatology ; differentiation ; Dihydrotestosterone - pharmacology ; DNA Fragmentation - drug effects ; DNA Fragmentation - physiology ; Enzyme Inhibitors - pharmacology ; Gene Expression ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Isotretinoin - pharmacology ; L-Lactate Dehydrogenase - metabolism ; Medical sciences ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Phosphatidylserines - metabolism ; Proto-Oncogene Proteins - analysis ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins c-bcl-2 - analysis ; Proto-Oncogene Proteins c-bcl-2 - genetics ; retinoids ; RNA, Messenger - analysis ; sebaceous gland ; Sebaceous Glands - chemistry ; Sebaceous Glands - cytology ; Sebaceous Glands - physiology ; Staurosporine - pharmacology</subject><ispartof>Journal of investigative dermatology, 2003-02, Vol.120 (2), p.175-181</ispartof><rights>2003 The Society for Investigative Dermatology, Inc</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Feb 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543t-c15439ac811329d951e554c036c31d58d47d6db4d74ff78ce36548b335a6a2d3</citedby><cites>FETCH-LOGICAL-c543t-c15439ac811329d951e554c036c31d58d47d6db4d74ff78ce36548b335a6a2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/210372929?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14925028$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12542519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wróbel, Anna</creatorcontrib><creatorcontrib>Seltmann, Holger</creatorcontrib><creatorcontrib>Fimmel, Sabine</creatorcontrib><creatorcontrib>Müller-Decker, Karin</creatorcontrib><creatorcontrib>Tsukada, Miki</creatorcontrib><creatorcontrib>Bogdanoff, Birgit</creatorcontrib><creatorcontrib>Mandt, Nathalie</creatorcontrib><creatorcontrib>Blume-Peytavi, Ulrike</creatorcontrib><creatorcontrib>Orfanos, Constantin E.</creatorcontrib><creatorcontrib>Zouboulis, Christos C.</creatorcontrib><title>Differentiation and Apoptosis in Human Immortalized Sebocytes</title><title>Journal of investigative dermatology</title><addtitle>J Invest Dermatol</addtitle><description>Increased cell volume, accumulation of lipid droplets in the cytoplasm, and nuclear degeneration are phenomena indicating terminal differentiation of human sebocytes followed by holocrine secretion and cell death. The molecular pathways of natural and induced sebocyte elimination are still unknown, however. In this study, SZ95 sebocytes were found to exhibit DNA fragmentation after a 6 h culture followed by increased lactate dehydrogenase release after 24 h, indicating cell damage. With the help of morphologic studies and using Oil Red detection of cellular lipids, cell enlargement, accumulation of lipid droplets in the cytoplasm, and nuclear fragmentation could be observed under treatment with arachidonic acid. Staurosporine, a potent inhibitor of phospholipid Ca2+-dependent protein kinase, increased externalized phosphatidylserine levels on SZ95 sebocytes, detected by annexin V/propidium iodide flow cytometry, as early as after 1 h, whereas dose-dependent reduction of bcl-2 mRNA and protein expression, enhanced DNA fragmentation, and increased caspase 3 levels, detected by caspase 3 inhibitor/propidium iodide flow cytometry, were found after 6 h of treatment. SZ95 sebocyte death was detected as early as after 6 h of SZ95 sebocyte treatment with high staurosporine concentrations (10−6–10−5 M). 5α-Dihydrotestosterone (10−8–10−5 M) did not affect externalized phosphatidylserine levels and DNA fragmentation in SZ95 sebocytes but slightly decreased lactate dehydrogenase cell release. Neither acitretin nor 13-cis retinoic acid (10−8–10−5 M) affected externalized phosphatidylserine levels, DNA fragmentation, and lactate dehydrogenase cell release, despite the increased caspase 3 levels under treatment with 13-cis retinoic acid. The combined staurosporine and 13-cis retinoic acid treatment enhanced DNA fragmentation in SZ95 sebocytes to the same magnitude as in cells only treated with staurosporine. In conclusion, SZ95 sebocytes in vitro undergo apoptosis, which can be enhanced by the terminal differentiation inductor arachidonic acid or by staurosporine and leads to cell death. 5α-Dihydrotestosterone inhibits SZ95 sebocyte death without involving apoptotic pathways, and retinoids did not affect the programmed death of human sebocytes. The latter result fits well with the currently reported inability of normal skin cells to undergo apoptosis after treatment with retinoids, in contrast to their malignant counterparts.</description><subject>apoptosis</subject><subject>Arachidonic Acid - pharmacology</subject><subject>bcl-2-Associated X Protein</subject><subject>Biological and medical sciences</subject><subject>Caspase 3</subject><subject>Caspases - metabolism</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Differentiation - physiology</subject><subject>cell line</subject><subject>Cell Line, Transformed</subject><subject>Dermatology</subject><subject>differentiation</subject><subject>Dihydrotestosterone - pharmacology</subject><subject>DNA Fragmentation - drug effects</subject><subject>DNA Fragmentation - physiology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Isotretinoin - pharmacology</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Medical sciences</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Phosphatidylserines - metabolism</subject><subject>Proto-Oncogene Proteins - analysis</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - analysis</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>retinoids</subject><subject>RNA, Messenger - analysis</subject><subject>sebaceous gland</subject><subject>Sebaceous Glands - chemistry</subject><subject>Sebaceous Glands - cytology</subject><subject>Sebaceous Glands - physiology</subject><subject>Staurosporine - pharmacology</subject><issn>0022-202X</issn><issn>1523-1747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkEtP3DAUhS1EBVPKX0AREuyS-hnHCxY8WkBC6qIs2Fke-0byKLEHO0HAr6-nMyoSm67u4nzn6OpDqCK4IZi331cNEZTVRHLZUIxZQyimqnndQ4t_wT5aYExpXZKnQ_Q15xXGpOWiO0CHhApOBVELdHHj-x4ShMmbycdQmeCqy3VcTzH7XPlQ3c2jCdX9OMY0mcG_g6t-wzLatwnyN_SlN0OG4909Qo8_fzxe39UPv27vry8fais4m2pLylHGdoQwqpwSBITgFrPWMuJE57h0rVtyJ3nfy84CawXvlowJ0xrq2BE6386uU3yeIU969NnCMJgAcc5aUiWlkm0BTz-BqzinUF7TlGBWOKoK1G0hm2LOCXq9Tn406U0TrDd69UpvLOqNRb3Rq__q1a-lerLbn5cjuI_izmcBznaAydYMfTLB-vzBcUUFpl3hrrYcFGsvHpLO1kOw4HwCO2kX_f-_-QPAKJdQ</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>Wróbel, Anna</creator><creator>Seltmann, Holger</creator><creator>Fimmel, Sabine</creator><creator>Müller-Decker, Karin</creator><creator>Tsukada, Miki</creator><creator>Bogdanoff, Birgit</creator><creator>Mandt, Nathalie</creator><creator>Blume-Peytavi, Ulrike</creator><creator>Orfanos, Constantin E.</creator><creator>Zouboulis, Christos C.</creator><general>Elsevier Inc</general><general>Nature Publishing</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20030201</creationdate><title>Differentiation and Apoptosis in Human Immortalized Sebocytes</title><author>Wróbel, Anna ; Seltmann, Holger ; Fimmel, Sabine ; Müller-Decker, Karin ; Tsukada, Miki ; Bogdanoff, Birgit ; Mandt, Nathalie ; Blume-Peytavi, Ulrike ; Orfanos, Constantin E. ; Zouboulis, Christos C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543t-c15439ac811329d951e554c036c31d58d47d6db4d74ff78ce36548b335a6a2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>apoptosis</topic><topic>Arachidonic Acid - pharmacology</topic><topic>bcl-2-Associated X Protein</topic><topic>Biological and medical sciences</topic><topic>Caspase 3</topic><topic>Caspases - metabolism</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Differentiation - physiology</topic><topic>cell line</topic><topic>Cell Line, Transformed</topic><topic>Dermatology</topic><topic>differentiation</topic><topic>Dihydrotestosterone - pharmacology</topic><topic>DNA Fragmentation - drug effects</topic><topic>DNA Fragmentation - physiology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Isotretinoin - pharmacology</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Medical sciences</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Phosphatidylserines - metabolism</topic><topic>Proto-Oncogene Proteins - analysis</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - analysis</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>retinoids</topic><topic>RNA, Messenger - analysis</topic><topic>sebaceous gland</topic><topic>Sebaceous Glands - chemistry</topic><topic>Sebaceous Glands - cytology</topic><topic>Sebaceous Glands - physiology</topic><topic>Staurosporine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wróbel, Anna</creatorcontrib><creatorcontrib>Seltmann, Holger</creatorcontrib><creatorcontrib>Fimmel, Sabine</creatorcontrib><creatorcontrib>Müller-Decker, Karin</creatorcontrib><creatorcontrib>Tsukada, Miki</creatorcontrib><creatorcontrib>Bogdanoff, Birgit</creatorcontrib><creatorcontrib>Mandt, Nathalie</creatorcontrib><creatorcontrib>Blume-Peytavi, Ulrike</creatorcontrib><creatorcontrib>Orfanos, Constantin E.</creatorcontrib><creatorcontrib>Zouboulis, Christos C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of investigative dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wróbel, Anna</au><au>Seltmann, Holger</au><au>Fimmel, Sabine</au><au>Müller-Decker, Karin</au><au>Tsukada, Miki</au><au>Bogdanoff, Birgit</au><au>Mandt, Nathalie</au><au>Blume-Peytavi, Ulrike</au><au>Orfanos, Constantin E.</au><au>Zouboulis, Christos C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiation and Apoptosis in Human Immortalized Sebocytes</atitle><jtitle>Journal of investigative dermatology</jtitle><addtitle>J Invest Dermatol</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>120</volume><issue>2</issue><spage>175</spage><epage>181</epage><pages>175-181</pages><issn>0022-202X</issn><eissn>1523-1747</eissn><coden>JIDEAE</coden><abstract>Increased cell volume, accumulation of lipid droplets in the cytoplasm, and nuclear degeneration are phenomena indicating terminal differentiation of human sebocytes followed by holocrine secretion and cell death. The molecular pathways of natural and induced sebocyte elimination are still unknown, however. In this study, SZ95 sebocytes were found to exhibit DNA fragmentation after a 6 h culture followed by increased lactate dehydrogenase release after 24 h, indicating cell damage. With the help of morphologic studies and using Oil Red detection of cellular lipids, cell enlargement, accumulation of lipid droplets in the cytoplasm, and nuclear fragmentation could be observed under treatment with arachidonic acid. Staurosporine, a potent inhibitor of phospholipid Ca2+-dependent protein kinase, increased externalized phosphatidylserine levels on SZ95 sebocytes, detected by annexin V/propidium iodide flow cytometry, as early as after 1 h, whereas dose-dependent reduction of bcl-2 mRNA and protein expression, enhanced DNA fragmentation, and increased caspase 3 levels, detected by caspase 3 inhibitor/propidium iodide flow cytometry, were found after 6 h of treatment. SZ95 sebocyte death was detected as early as after 6 h of SZ95 sebocyte treatment with high staurosporine concentrations (10−6–10−5 M). 5α-Dihydrotestosterone (10−8–10−5 M) did not affect externalized phosphatidylserine levels and DNA fragmentation in SZ95 sebocytes but slightly decreased lactate dehydrogenase cell release. Neither acitretin nor 13-cis retinoic acid (10−8–10−5 M) affected externalized phosphatidylserine levels, DNA fragmentation, and lactate dehydrogenase cell release, despite the increased caspase 3 levels under treatment with 13-cis retinoic acid. The combined staurosporine and 13-cis retinoic acid treatment enhanced DNA fragmentation in SZ95 sebocytes to the same magnitude as in cells only treated with staurosporine. In conclusion, SZ95 sebocytes in vitro undergo apoptosis, which can be enhanced by the terminal differentiation inductor arachidonic acid or by staurosporine and leads to cell death. 5α-Dihydrotestosterone inhibits SZ95 sebocyte death without involving apoptotic pathways, and retinoids did not affect the programmed death of human sebocytes. The latter result fits well with the currently reported inability of normal skin cells to undergo apoptosis after treatment with retinoids, in contrast to their malignant counterparts.</abstract><cop>Danvers, MA</cop><pub>Elsevier Inc</pub><pmid>12542519</pmid><doi>10.1046/j.1523-1747.2003.12029.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-202X
ispartof Journal of investigative dermatology, 2003-02, Vol.120 (2), p.175-181
issn 0022-202X
1523-1747
language eng
recordid cdi_proquest_miscellaneous_72977976
source MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection
subjects apoptosis
Arachidonic Acid - pharmacology
bcl-2-Associated X Protein
Biological and medical sciences
Caspase 3
Caspases - metabolism
Cell Differentiation - drug effects
Cell Differentiation - physiology
cell line
Cell Line, Transformed
Dermatology
differentiation
Dihydrotestosterone - pharmacology
DNA Fragmentation - drug effects
DNA Fragmentation - physiology
Enzyme Inhibitors - pharmacology
Gene Expression
Humans
Investigative techniques, diagnostic techniques (general aspects)
Isotretinoin - pharmacology
L-Lactate Dehydrogenase - metabolism
Medical sciences
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
Phosphatidylserines - metabolism
Proto-Oncogene Proteins - analysis
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins c-bcl-2 - analysis
Proto-Oncogene Proteins c-bcl-2 - genetics
retinoids
RNA, Messenger - analysis
sebaceous gland
Sebaceous Glands - chemistry
Sebaceous Glands - cytology
Sebaceous Glands - physiology
Staurosporine - pharmacology
title Differentiation and Apoptosis in Human Immortalized Sebocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T15%3A16%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiation%20and%20Apoptosis%20in%20Human%20Immortalized%20Sebocytes&rft.jtitle=Journal%20of%20investigative%20dermatology&rft.au=Wr%C3%B3bel,%20Anna&rft.date=2003-02-01&rft.volume=120&rft.issue=2&rft.spage=175&rft.epage=181&rft.pages=175-181&rft.issn=0022-202X&rft.eissn=1523-1747&rft.coden=JIDEAE&rft_id=info:doi/10.1046/j.1523-1747.2003.12029.x&rft_dat=%3Cproquest_cross%3E1038893991%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=210372929&rft_id=info:pmid/12542519&rft_els_id=S0022202X15301688&rfr_iscdi=true